Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

C7. Bacteremia

Session: GNB bacteremia

60 - Creation and Comparison of a Machine Learning Decision Tree and Traditional Risk Score to Predict Ceftriaxone Resistance in Cancer Patients with E. coli Bacteremia

On Demand
Participants should be aware of the following financial/non-financial relationships:
Courtney Moc, PharmD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
William Shropshire, MPH, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Patrick McDaneld, PharmD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Samuel A. Shelburne, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Samuel L. Aitken, PharmD, MPH, BCIDP: Melinta Therapeutoics (Individual(s) Involved: Self): Consultant, Grant/Research Support

    Presenting Author(s)

  • Courtney Moc, PharmD, MS

    PGY2 Infectious Diseases Pharmacy Resident
    UT MD Anderson Cancer Center
    Los Angeles, CA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    Slides Slides and Audio

    • Co-Author(s)

  • WS

    William Shropshire, MPH, PhD

    UT MD Anderson Cancer Center
    Houston, Texas, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • PM

    Patrick McDaneld, PharmD

    Clinical Pharmacy Specialist
    University of Texas MD Anderson Cancer Center
    Houston, TX, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Samuel A. Shelburne, MD, PhD

    Professor
    The University of Texas MD Anderson Cancer Center
    Houston, TX, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Samuel L. Aitken, PharmD, MPH, BCIDP

    Clinical Pharmacist Specialist - Infectious Diseases
    Michigan Medicine
    Ann Arbor, TX, United States

    Melinta (Consultant, Grant/Research Support)